Russell Investments Group, Ltd. Mei Pharma, Inc. Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$1.65 - $2.48 $495 - $744	-300 Reduced 0.6%	49,822 $123,000
Q3 2019 Nov 01, 2019	BUY	$1.48 - $2.52 $40,880 - $69,607	27,622 Added 122.76%	50,122 $84,000
Q2 2019 Aug 09, 2019	BUY	$2.45 - $3.32 $55,125 - $74,700	22,500 New	22,500 $56,000
Q4 2018 Feb 11, 2019	SELL	$1.92 - $4.1 $82,656 - $176,504	-43,050 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$3.39 - $4.61 $13,221 - $17,979	-3,900 Reduced 8.31%	43,050 $186,000
Q2 2018 Aug 08, 2018	SELL	$1.89 - $4.95 $142,334 - $372,779	-75,309 Reduced 61.6%	46,950 $185,000
Q1 2018 May 11, 2018	SELL	$2.06 - $2.38 $55,731 - $64,388	-27,054 Reduced 18.12%	122,259 $253,000
Q4 2017 Feb 06, 2018	SELL	$1.91 - $2.83 $104,832 - $155,327	-54,886 Reduced 26.88%	149,313 $298,000
Q3 2017 Nov 07, 2017	BUY	$2.44 - $2.91 $498,245 - $594,219	204,199	204,199 $547,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $356M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.